Allergy

Latest News


CME Content


An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.

Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.

Children diagnosed with attention-deficit/hyperactivity disorder may be more likely to be diagnosed with asthma as well, according to the results of a new study.

Sara Anvari, MD, discusses the function of histamine in the immune response and treatment with antihistamines.

Ocular Allergy

By

Leonard Bielory, MD, reviews challenging cases of ocular allergy and discusses treatment options.